{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:48:12Z","timestamp":1769003292352,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/pcan.2017.21","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T10:21:12Z","timestamp":1493115672000},"page":"348-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multiparametric MRI\/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men"],"prefix":"10.1038","volume":"20","author":[{"given":"M","family":"Kongnyuy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M M","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Muthigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sidana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Maruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Turkbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P L","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B J","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"BFpcan201721_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2015","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A . Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomarkers Prev 2015; 25: 16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201721_CR2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079\u20131092.","journal-title":"Eur Urol"},{"key":"BFpcan201721_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","volume":"361","author":"H Gronberg","year":"2003","unstructured":"Gronberg H . Prostate cancer epidemiology. Lancet (London, England) 2003; 361: 859\u2013864.","journal-title":"Lancet (London, England)"},{"key":"BFpcan201721_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21340","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. Cancer J Clin 2016; 66: 290\u2013308.","journal-title":"Cancer J Clin"},{"key":"BFpcan201721_CR5","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM . Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893\u20131907.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201721_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.juro.2008.10.010","volume":"181","author":"DC Miller","year":"2009","unstructured":"Miller DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L et al. Prostate cancer severity among low income, uninsured men. J Urol 2009; 181: 579\u2013583;discussion 83\u201384.","journal-title":"J Urol"},{"key":"BFpcan201721_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N et al. Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313: 390\u2013397.","journal-title":"JAMA"},{"key":"BFpcan201721_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.urolonc.2014.02.001","volume":"32","author":"M Scialpi","year":"2014","unstructured":"Scialpi M, Piscioli I, Malaspina S, D'Andrea A . Multiparametric magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: role in diagnosis and management of prostatic cancer. Urol Oncol 2014; 32: 509\u2013510.","journal-title":"Urol Oncol"},{"key":"BFpcan201721_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.urolonc.2013.08.006","volume":"32","author":"GA Sonn","year":"2014","unstructured":"Sonn GA, Margolis DJ, Marks LS . Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol 2014; 32: 903\u2013911.","journal-title":"Urol Oncol"},{"key":"BFpcan201721_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.09090475","volume":"255","author":"B Turkbey","year":"2010","unstructured":"Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL et al. Prostate cancer: value of multiparametric MR imaging at 3T for detection\u2014histopathologic correlation. Radiology 2010; 255: 89\u201399.","journal-title":"Radiology"},{"key":"BFpcan201721_CR11","doi-asserted-by":"publisher","first-page":"E783","DOI":"10.1111\/j.1464-410X.2012.11646.x","volume":"110","author":"NK Yerram","year":"2012","unstructured":"Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S et al. Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012; 110: E783\u2013E788.","journal-title":"BJU Int"},{"key":"BFpcan201721_CR12","unstructured":"Radiology ACo. Prostate Imaging Reporting and Data System (PIRADS). Available at: http:\/\/www.acr.org\/Quality-Safety\/Resources\/PIRADS. Last accessed April 2016."},{"key":"BFpcan201721_CR13","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.juro.2010.01.015","volume":"183","author":"IJ Powell","year":"2010","unstructured":"Powell IJ, Bock CH, Ruterbusch JJ, Sakr W . Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 2010; 183: 1792\u20131796.","journal-title":"J Urol"},{"key":"BFpcan201721_CR14","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1158\/1055-9965.EPI-08-0203","volume":"17","author":"BA Jones","year":"2008","unstructured":"Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2825\u20132834.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201721_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jnci\/djp175","volume":"101","author":"KS Albain","year":"2009","unstructured":"Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL . Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009; 101: 984\u2013992.","journal-title":"J Natl Cancer Inst"},{"key":"BFpcan201721_CR16","doi-asserted-by":"crossref","unstructured":"Shin T, Smyth TB, Ukimura O, Ahmadi N, de Castro Abreu AL, Oishi M et al. Detection of prostate cancer using magnetic resonance imaging\/ultrasonography image-fusion targeted biopsy in African-American men. BJU Int 2017.","DOI":"10.1111\/bju.13786"},{"key":"BFpcan201721_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.juro.2016.08.097","volume":"197","author":"A Muthigi","year":"2017","unstructured":"Muthigi A, George AK, Sidana A, Kongnyuy M, Simon R, Moreno V et al. Missing the mark: prostate cancer upgrading by systematic biopsy over magnetic resonance imaging\/transrectal ultrasound fusion biopsy. J Urol 2017; 197: 327\u2013334.","journal-title":"J Urol"},{"key":"BFpcan201721_CR18","doi-asserted-by":"publisher","first-page":"254.e15","DOI":"10.1016\/j.urolonc.2015.12.018","volume":"34","author":"M Kongnyuy","year":"2016","unstructured":"Kongnyuy M, Sidana A, George AK, Muthigi A, Iyer A, Fascelli M et al. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. Urol Oncol 2016; 34: 254.e15\u2013254.e21.","journal-title":"Urol Oncol"},{"key":"BFpcan201721_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11934-016-0589-z","volume":"17","author":"M Kongnyuy","year":"2016","unstructured":"Kongnyuy M, George AK, Rastinehad AR, Pinto PA . Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes. Curr Urol Rep 2016; 17: 32.","journal-title":"Curr Urol Rep"},{"key":"BFpcan201721_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","volume":"196","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: A Consensus Statement by AUA and SAR. J Urol 2016; 196: 1613\u20131618.","journal-title":"J Urol"},{"key":"BFpcan201721_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.juro.2015.12.102","volume":"195","author":"AR Rastinehad","year":"2016","unstructured":"Rastinehad AR, Abboud SF, George AK, Frye T, Ho R, Chelluri R et al. Reproducibility of multiparametric MRI and fusion-guided prostate biopsy: multi-institutional external validation by a propensity score matched cohort. J Urol 2016; 195: 1737\u20131743.","journal-title":"J Urol"},{"key":"BFpcan201721_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.eururo.2011.05.006","volume":"60","author":"G Ploussard","year":"2011","unstructured":"Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 2011; 60: 291\u2013303.","journal-title":"Eur Urol"},{"key":"BFpcan201721_CR23","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","volume":"15","author":"LJ Esserman","year":"2014","unstructured":"Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch HG et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014; 15: e234\u2013e242.","journal-title":"Lancet Oncol"},{"key":"BFpcan201721_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.urology.2014.08.014","volume":"85","author":"D Sundi","year":"2015","unstructured":"Sundi D, Faisal FA, Trock BJ, Landis PK, Feng Z, Ross AE et al. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology 2015; 85: 155\u2013160.","journal-title":"Urology"},{"key":"BFpcan201721_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1464-410X.1997.00126.x","volume":"79","author":"ET Fernandes","year":"1997","unstructured":"Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ . Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 1997; 79: 615\u2013617.","journal-title":"Br J Urol"},{"key":"BFpcan201721_CR26","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.eururo.2005.11.007","volume":"49","author":"FK Chun","year":"2006","unstructured":"Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006; 49: 820\u2013826.","journal-title":"Eur Urol"},{"key":"BFpcan201721_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","volume":"68","author":"M Valerio","year":"2015","unstructured":"Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS et al. Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 2015; 68: 8\u201319.","journal-title":"Eur Urol"},{"key":"BFpcan201721_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2012.06.004","volume":"63","author":"CM Moore","year":"2013","unstructured":"Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63: 125\u2013140.","journal-title":"Eur Urol"},{"key":"BFpcan201721_CR29","doi-asserted-by":"publisher","first-page":"32.e1","DOI":"10.1016\/j.urolonc.2016.08.008","volume":"35","author":"A Muthigi","year":"2017","unstructured":"Muthigi A, Sidana A, George AK, Kongnyuy M, Maruf M, Valayil S et al. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. Urol Oncol 2017; 35: 32.e1\u201332.e7.","journal-title":"Urol Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201721","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pcan.2017.21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:12:24Z","timestamp":1648674744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFpcan201721"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2017.21","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]},"assertion":[{"value":"23 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}